MK

Mike Kratky Leerink Partners Latest Price Targets & Analyst Ratings

Stock Price Price Target Upside
Downside
Rating Date
INSP icon
1
Inspire Medical Systems
INSP
$2.56B
$86.46 $97
12%
upside
Market Perform 23 days ago
BSX icon
2
Boston Scientific
BSX
$159B
$107.22 $118
10%
upside
Outperform 2 months ago
MDT icon
3
Medtronic
MDT
$119B
$92.90 $110
18%
upside
Outperform 2 months ago
BBNX
4
Beta Bionics, Inc. Common Stock
BBNX
$878M
$20.20 $28
39%
upside
Outperform 6 months ago
TXG icon
5
10x Genomics
TXG
$1.74B
$13.96 $12
14%
downside
Market Perform 6 months ago
DXCM icon
6
DexCom
DXCM
$31.6B
$80.51 $87
8%
upside
Outperform 10 months ago
PEN icon
7
Penumbra
PEN
$11B
$281.46 $263
7%
downside
Outperform 1 year ago
TNDM icon
8
Tandem Diabetes Care
TNDM
$850M
$12.58 $45
258%
upside
Outperform 1 year ago
NPCE icon
9
Neuropace
NPCE
$322M
$9.73 $22
126%
upside
Outperform 1 year ago
PODD icon
10
Insulet
PODD
$24.5B
$348.43 $184
47%
downside
Outperform 1 year ago
VCEL icon
11
Vericel Corp
VCEL
$1.72B
$34.05 $42
23%
upside
Outperform 1 year ago
ISRG icon
12
Intuitive Surgical
ISRG
$167B
$466.86 $342
27%
downside
Outperform 1 year ago
EW icon
13
Edwards Lifesciences
EW
$47.5B
$80.94 $75
7%
downside
Market Perform 1 year ago
PRCT icon
14
Procept Biorobotics
PRCT
$2.26B
$40.68 $37
9%
downside
Outperform 1 year ago
AXGN icon
15
Axogen
AXGN
$735M
$15.98 $9
44%
downside
Outperform 1 year ago
MDGL icon
16
Madrigal Pharmaceuticals
MDGL
$9.65B
$432.89 $315
27%
downside
Outperform 2 years ago
KYMR icon
17
Kymera Therapeutics
KYMR
$3.11B
$43.51 $31
29%
downside
Market Perform 2 years ago
IMVT icon
18
Immunovant
IMVT
$2.99B
$17.14 $14
18%
downside
Outperform 2 years ago
VRDN icon
19
Viridian Therapeutics
VRDN
$1.53B
$18.72 $40
114%
upside
Outperform 3 years ago